NY-ESO-1 specific antibodies are frequently detected in hight-risk myeloma.

被引：0
|
作者：
van Rhee, F
Szmania, SM
Pomtree, M
Zhan, F
Moreno, A
Rosen, N
Fox, M
Barlogie, B
Shaughnessy, J
Batchu, R
Tricot, GJ
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2464
引用
收藏
页码：676A / 676A
页数：1
相关论文
共 50 条
  • [1] NY-ESO-1 immunotherapy for multiple myeloma
    Szmania, Susann
    Tricot, Guido
    van Rhee, Frits
    LEUKEMIA & LYMPHOMA, 2006, 47 (10) : 2037 - 2048
  • [2] Pre-existent humoral and cellular immunity to NY-ESO-1 in multiple myeloma.
    Szmania, SM
    Pomtree, M
    Batchu, RB
    Moreno, A
    Zhan, FH
    Gupta, SK
    Cottler-Fox, MH
    Barlogie, B
    Tricot, G
    Shaughnessy, J
    Van Rhee, F
    BLOOD, 2003, 102 (11) : 930A - 930A
  • [3] NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
    Chen, Ji-Li
    Dawoodji, Amina
    Tarlton, Andrea
    Gnjatic, Sacha
    Tajar, Abdelouahid
    Karydis, Ioannis
    Browning, Judy
    Pratap, Sarah
    Verfaille, Christian
    Venhaus, Ralph R.
    Pan, Linda
    Altman, Douglas G.
    Cebon, Jonathan S.
    Old, Lloyd L.
    Nathan, Paul
    Ottensmeier, Christian
    Middleton, Mark
    Cerundolo, Vincenzo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) : E590 - E601
  • [4] Public NY-ESO-1 specific TCRs as novel biomarkers for immune monitoring of NY-ESO-1 positive cancer patients
    Lu, Hailing
    Pollack, Seth
    Somaiah, Neeta
    Chawla, Sant
    Hwu, Patrick
    Vignali, Marissa
    Rytlewski, Julie
    Gnjatic, Sacha
    ter Meulen, Jan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [5] Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma
    Maruta, Masaki
    Ochi, Toshiki
    Tanimoto, Kazushi
    Azuma, Taichi
    Fujiwara, Hiroshi
    Yasukawa, Masaki
    BLOOD, 2017, 130
  • [6] Development of antimyeloma immunotherapy by exploiting modified antibodies specific for A2/NY-ESO-1
    Ochi, Toshiki
    Maruta, Masaki
    Tanimoto, Kazushi
    Asai, Hiroaki
    Saitou, Takashi
    Yakushijin, Yoshihiro
    Fujiwara, Hiroshi
    Imamura, Takeshi
    Takenaka, Katsuto
    Yasukawa, Masaki
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [7] NY-ESO-1 specific T-cells are spontaneously present in high-risk myeloma and kill primary myeloma cells.
    van Rhee, F
    Szmania, SM
    Moreno, A
    Batchu, R
    Pomtree, M
    Rosen, N
    Cottler-Fox, M
    Barlogie, B
    Trico, GJ
    BLOOD, 2004, 104 (11) : 674A - 674A
  • [8] Intra- and intertumoral variation in the expression of Cancer Testis antigens, MAGE-3 and NY-ESO-1 in multiple myeloma.
    Gupta, SK
    Lin, P
    Droogenbroeck, J
    Szmania, S
    Yacobby, S
    Batchu, R
    Spagnoli, G
    Tricot, G
    Epstein, J
    van Rhee, F
    BLOOD, 2002, 100 (11) : 603A - 603A
  • [9] Smoking History Affects the Production of Tumor Antigen Specific Antibodies NY-ESO-1 in Patients with Lung Cancer
    Mysikova, D.
    Adkins, I.
    Hradilova, N.
    Palata, O.
    Simonek, J.
    Kolarik, J.
    Pozniak, J.
    Fialova, A.
    Spisek, R.
    Lischke, R.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2383 - S2384
  • [10] NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
    Aaron P Rapoport
    Edward A Stadtmauer
    Gwendolyn K Binder-Scholl
    Olga Goloubeva
    Dan T Vogl
    Simon F Lacey
    Ashraf Z Badros
    Alfred Garfall
    Brendan Weiss
    Jeffrey Finklestein
    Irina Kulikovskaya
    Sanjoy K Sinha
    Shari Kronsberg
    Minnal Gupta
    Sarah Bond
    Luca Melchiori
    Joanna E Brewer
    Alan D Bennett
    Andrew B Gerry
    Nicholas J Pumphrey
    Daniel Williams
    Helen K Tayton- Martin
    Lilliam Ribeiro
    Tom Holdich
    Saul Yanovich
    Nancy Hardy
    Jean Yared
    Naseem Kerr
    Sunita Philip
    Sandra Westphal
    Don L Siegel
    Bruce L Levine
    Bent K Jakobsen
    Michael Kalos
    Carl H June
    Nature Medicine, 2015, 21 : 914 - 921
12345